Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.283NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.96NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.96NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.96NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
L.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
L.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.310NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.310NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.310NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.185NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.185NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.185NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.329NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.329NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.329NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.229NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.229NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.229NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.342NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.342NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.342NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.90NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.90NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.90NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.169NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.169NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.169NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.528NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.528NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.528NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.175NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.175NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.175NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.6.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.483NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used